SN

Science 37 Holdings IncNASDAQ SNCE Stock Report

Last reporting period 30 Sep, 2023

Updated —

Last price

Market cap $B

0.035

Micro

Exchange

XNAS - Nasdaq

SNCE Stock Analysis

SN

Uncovered

Science 37 Holdings Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.035

Dividend yield

Shares outstanding

116.73 B

Science 37 Holdings, Inc. provides technology-based solutions that enables decentralized clinical trials. The company is headquartered in Research Triangle Park, North Carolina and currently employs 460 full-time employees. The company went IPO on 2020-11-20. The firm has developed agile and decentralization methods and the Agile Clinical Trial Operating System (OS), which combines its unified technology platform, which orchestrates workflows, generates evidence and harmonizes data seamlessly, with its expansive centralized networks of patient communities, telemedicine investigators, mobile nursing, community providers, remote coordinators and data and devices. The firm's offerings include the Agile Clinical Trial, Decentralized Clinical Trials, Metasite, Technology Platform, Study Configurations and Diversity & Inclusion. Its open application programming interface (API) allows for the structured exchange of data in nearly real-time, including electronic data capture (EDC) and electronic health record (EHR) integrations.

View Section: Eyestock Rating